PhillyPharma Archive: February, 2013

Merck quarterly profit drops, will delay FDA application on osteoporosis drug

Comment icon 0 Comments
Merck's fourth-quarter profit fell seven percent as sales of its former best-selling drug Singulair were depressed by generic competition and... Read more

Zoetis loves dogs and cats, but really loves cows and pigs

Comment icon 0 Comments
UPDATE: Zoetis, which stock market folks said was the biggest IPO since Facebook, had a good first day. The stock started at $26 per share... Read more